Results 231 to 240 of about 785,669 (310)
Immune checkpoint inhibitors (ICIs) have transformed cancer therapy, but their efficacy continues to be limited by immune‐related adverse events. Among these, ICI‐induced cardiac arrhythmias are increasingly recognised as a major adverse reaction, encompassing a broad spectrum of clinical phenotypes, including conduction blocks, atrial fibrillation and
Anand R. Ramalingam +3 more
wiley +1 more source
The current obesity drug landscape, dominated by GLP‐1 receptor agonists and emerging multi‐agonist therapies, has reinforced that long‐term weight loss is achieved in large part through central mechanisms that suppress appetite and reshape energy balance.
Ines Martinez‐Corral +3 more
wiley +1 more source
Stepwise Evolution of Immunodeficient Mouse Models: Focus on NCG Strains and Their Applications in Humanized Immune System Research. [PDF]
Sun H +6 more
europepmc +1 more source
Background and Purpose The neuropeptide calcitonin gene‐related peptide (CGRP) is a well‐established player in migraine. Current CGRP migraine therapeutics were designed to inhibit the canonical CGRP receptor, yet, based on in vitro studies, they can also inhibit to a lesser degree the amylin receptor 1 (AMY1), which CGRP can also activate.
Jayme S. Waite +10 more
wiley +1 more source
A dual-action humanized DKK-1 antibody that activates the Wnt/β-catenin signaling pathway and inhibits the RANKL signaling pathway for osteoporosis therapy. [PDF]
Hou S +8 more
europepmc +1 more source
Expanding the Utility of Gold Nanocluster “Allergolds” to Peanut Allergen Ara h 2
Allergy, EarlyView.
Gage O. Leighton +10 more
wiley +1 more source
Development and Humanization of a Camelid-Derived Neutralizing Nanobody Targeting Botulinum Neurotoxin Type A. [PDF]
Jiang Y +8 more
europepmc +1 more source
The Role of Human Viral Entry Receptor Mouse Models in Advancing Antiviral Antibodies and Vaccines. [PDF]
Zuo N, Zheng X, Ishaq R, Ren D, Hu A.
europepmc +1 more source
Artificial intelligence-assisted design of MAGE-A4 ×CD16 T-cell receptor-like natural killer cell engagers. [PDF]
Liu Y +10 more
europepmc +1 more source

